Nomogram Predicting Overall Survival in Operable Cervical Cancer Patients

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Ru-Ru ZhengFeng Lin

Abstract

Nomograms are widely used as predictive tools to predict oncological outcomes intuitively and precisely. The aim of our study was to develop a nomogram for predicting overall survival (OS) of patients with early stage cervical cancer. In this retrospective study, the clinical, pathological, and hematological data and prognosis of 795 cervical cancer patients were investigated. We identified and incorporated independent significant prognostic factors for OS to develop a nomogram. The predictive accuracy and discriminative ability were measured by concordance index. By univariable analysis and subsequent multivariable analysis, we identified body mass index, albumin, platelet, leukocyte, tumor differentiation, and the status of the pelvic lymph node (PLN) (all P < 0.05) as independent prognostic factors. The concordance index of the nomogram integrating these 6 variables was 0.74. The calibration curves for probability of 3- and 5-year OS also demonstrated ideal agreement between nomogram prediction and actual observation. We developed a novel nomogram that can provide prediction of OS for patients with early stage cervical cancer individually. Furthermore, studies are required to validate whether it can be applied to other cohorts.

References

Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E H Avall-LundqvistP H Eneroth
Aug 1, 1988·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·P W GrigsbyM A Hederman
Dec 1, 1985·Annals of Internal Medicine·L Garfinkel
Mar 1, 2000·Statistics in Medicine·D G Altman, P Royston
Apr 14, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W A PetersD S Alberts
Apr 25, 2003·The New England Journal of Medicine·Eugenia E CalleMichael J Thun
Jul 5, 2003·Lancet·Steven E Waggoner
Jun 15, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert PearceyWilliam J Mackillop
Sep 1, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C CoutantE Darai
Apr 9, 2008·Cancer Causes & Control : CCC·Karsten MünstedtFolker E Franke
Nov 13, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration
Sep 11, 2009·Gynecologic Oncology·Petra BiewengaMarrije R Buist
Nov 26, 2009·American Journal of Obstetrics and Gynecology·Jen-Yu TsengChi-Mou Juang
Mar 23, 2010·Cell·Sergei I GrivennikovMichael Karin
Aug 5, 2010·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Stephan PolterauerLukas Hefler
Apr 26, 2011·Gynecologic Oncology·Seiji MabuchiTadashi Kimura
Jul 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vincenzo ValentiniPhilippe Lambin
Aug 9, 2012·British Journal of Cancer·S PolterauerG Heinze
Sep 26, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dong-Seok HanHan-Kwang Yang
Jun 10, 2014·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Hyoung Uk JeJoo-Young Kim
Jan 28, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wenhua LiangJianxing He
May 20, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Hang ZhouShuang Li
Jul 2, 2015·Gynecologic Oncology·Fraukje J M PolLeon F A G Massuger
Jul 17, 2015·JAMA Oncology·UNKNOWN Global Burden of Disease Cancer CollaborationMohsen Naghavi

❮ Previous
Next ❯

Citations

Aug 24, 2020·Gynecologic Oncology·Amandine MaulardSebastien Gouy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.